USPTO Examiner IGEL JR MARK ALAN - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18963373PROXIMAL-FEMUR INTRAOSSEOUS RELEASE DEVICENovember 2024March 2025Allow410NoNo
18850758MANUAL CONTROL HANDHELD PRESSURE-ADJUSTABLE IRRIGATION AND SUCTION ELECTROCOAGULATION CUTTERSeptember 2024March 2025Allow600NoNo
18393582OPHTHALMOLOGICAL SURGERY MICROSURGERY INSTRUMENTS AND METHODS OF USE IN PARS PLANA VITRECTOMY FOR INCREASING SURGICAL PRECISION AND REDUCING VITREORETINAL INSTRUMENT INSERTIONS AND REMOVALS AND RELATED TRAUMADecember 2023November 2024Abandon1101NoNo
18238298Blood Control for a Catheter Insertion DeviceAugust 2023May 2025Allow2000NoNo
18178728CONTROLLED FLOW DRUG DELIVERY IMPLANTABLE DEVICEMarch 2023September 2023Allow610YesNo
18000925SYRINGE INJECTOR WITH A FEEDBACK MECHANISMDecember 2022January 2024Abandon1310NoNo
17893577OPHTHALMOLOGICAL SURGERY MICROSURGERY INSTRUMENTS AND METHODS OF USE IN PARS PLANA VITRECTOMY FOR INCREASING SURGICAL PRECISION AND REDUCING VITREORETINAL INSTRUMENT INSERTIONS AND REMOVALS AND RELATED TRAUMAAugust 2022January 2024Abandon1711NoNo
17866621OCULAR SURGICAL WORK TIP ADAPTERJuly 2022April 2025Allow3320NoNo
17812397METHODS AND DEVICES FOR VASCULAR ACCESSJuly 2022January 2023Allow610YesNo
17846416CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICEJune 2022April 2024Allow2210NoNo
17838881INTRAOSSEOUS DEVICE HAVING RETRACTABLE MOTOR/STYLET ASSEMBLY AND AUTOMATIC STYLET POINT COVER UPON RETRACTION OPERATIONJune 2022November 2024Abandon2920NoNo
17826799SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODSMay 2022February 2024Allow2110YesNo
17704589MEDICATION INJECTION SYSTEMMarch 2022April 2024Allow2510NoNo
17669899Devices and Methods for Delivering Fluid to a Nasal CavityFebruary 2022December 2024Allow3410NoNo
17564388CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICEDecember 2021April 2022Allow400NoNo
17493570Transradial Sheath Support and Hemostasis Device and MethodOctober 2021April 2024Allow3010NoNo
17474545Catheter Assembly With Angle Changing and Related MethodsSeptember 2021May 2025Allow4420NoNo
17469613Aspiration Apparatus for Intraosseous Access SystemSeptember 2021May 2025Allow4421NoNo
17405996Catheter Assembly Including Transitioning LumensAugust 2021April 2025Allow4440NoNo
17322942METHOD FOR MANUFACTURING NUCLEIC ACID FILM AND APPARATUS FOR INJECTING MEDICINE USING NUCLEIC ACID FILMMay 2021March 2025Allow4610YesNo
17323348POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLESMay 2021October 2024Abandon4110NoNo
17307630NEEDLELESS CONNECTOR WITH COMPRESSIBLE AND DEFLECTABLE VALVEMay 2021April 2024Allow3511NoNo
17279415CONNECTORMarch 2021April 2024Allow3710NoNo
17181808VIAL SUPPORTER FOR MEDICAMENT PUMPFebruary 2021February 2024Allow3610YesNo
17164517DELIVERY DEVICE FOR BIOLOGIC MATERIALFebruary 2021November 2024Abandon4510NoNo
17147240RESPIRATORY CARE SYSTEM WITH ELECTRONIC INDICATORJanuary 2021May 2025Allow5220YesYes
17259606CATHETERJanuary 2021June 2024Abandon4110NoNo
17259774FLUID PRODUCT INJECTION DEVICEJanuary 2021January 2025Allow4810NoNo
17259783FLUID INJECTION DEVICEJanuary 2021January 2025Allow4810NoNo
17259227METHOD AND APPARATUSJanuary 2021November 2024Abandon4611NoNo
17135571AGENT DELIVERY SYSTEMS AND METHODS OF USING THE SAMEDecember 2020May 2024Allow4110NoNo
17131259COUPLING DEVICEDecember 2020April 2023Abandon2810NoNo
17127588FLUSH INSTRUMENT WITH BLOOD EXPOSURE PROTECTION AND RELATED METHODSDecember 2020February 2024Allow3711NoNo
17127151PERI-VASCULAR TISSUE ABLATION CATHETERSDecember 2020April 2024Allow4010NoNo
17123708AGENT DELIVERY DEVICEDecember 2020March 2025Allow5121NoNo
17116768MEDICAL DEVICE FOR TREATING A VEINDecember 2020October 2022Allow2200NoNo
17085816SYSTEMS AND APPARATUS FOR DRIP RATE MEASUREMENT FOR MEDICAL FLUID ADMINISTRATIONOctober 2020October 2023Allow3610NoNo
17032059DEVICE AND METHODOLOGY FOR PREPARING SKIN FOR SELF-INJECTIONSeptember 2020April 2023Abandon3110NoNo
17011676DEAD END CONTAINER AND CONTAINER ASSEMBLY WITH DEAD END CONTAINERSeptember 2020May 2025Allow5640NoNo
16971432PERITONEAL DIALYSIS MACHINEAugust 2020November 2024Abandon5121NoNo
16992243Drive mechanismAugust 2020April 2024Allow4440YesNo
16962739AUTOMATIC INJECTION SYSTEMJuly 2020December 2021Allow1710YesNo
16900792INFUSION SETJune 2020April 2023Allow3411YesNo
16884802FLUID DELIVERY DEVICE WITH SENSORMay 2020March 2023Allow3410NoNo
16875377Catheter Device System and Method of UseMay 2020April 2024Allow4750YesNo
16760351Apparatus and Method for Intracranial Drug InjectionApril 2020June 2023Allow3720NoNo
16802778Devices and Methods for Delivering Fluid to a Nasal CavityFebruary 2020October 2021Allow1910NoNo
16642568Methods and Devices for Use in Treatment of Plantar Fasciitis and Fat GraftingFebruary 2020October 2023Allow4411YesNo
16798153ASPIRATION AND INJECTION DEVICEFebruary 2020September 2023Allow4320YesNo
16788839SALIVA SOLUTION METERING APPARATUS WITH DELIVERY TUBE RETAINING MOUTHPIECEFebruary 2020April 2023Allow3820NoNo
16787077TAKE-HOME DRUG DELIVERY SYSTEMFebruary 2020May 2025Allow6060YesNo
16777248CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICEJanuary 2020December 2021Allow2210YesNo
16775749AUTOMATIC DRUG DELIVERY DEVICEJanuary 2020October 2022Allow3310NoNo
16632822TIP FOR INTRA-TYMPANIC INJECTIONJanuary 2020April 2023Allow3820YesNo
16630656APPARATUS AND METHOD FOR OPENING AND CLOSING AN INFUSION TUBE CLAMPJanuary 2020April 2024Allow5121YesNo
16729205LIQUID MEDICINE INJECTION DEVICEDecember 2019April 2023Allow4010NoNo
16722177Large Bore Enteral ConnectorDecember 2019April 2024Allow5230YesNo
16696844Blood Control for a Catheter Insertion DeviceNovember 2019April 2023Allow4110NoNo
16694267SYSTEMS AND METHODS FOR ENHANCING UPTAKE OF THERAPEUTIC AGENT FROM BLOODSTREAM INTO DISEASE SITENovember 2019April 2023Abandon4110NoNo
16691579SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODSNovember 2019October 2022Allow3510NoNo
16690086DRUG DELIVERY DEVICE WITH DOSE KNOB CLUTCHNovember 2019January 2024Allow4920NoNo
16687664Systems and Methods Related to SyringesNovember 2019January 2024Allow5030YesNo
16613766SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODSNovember 2019October 2021Allow2320YesNo
16683126SYSTEM AND METHOD FOR MICRODOSE INJECTIONNovember 2019March 2022Allow2910NoNo
16594390FLUID DELIVERY DEVICE WITH HYDROPHOBIC SURFACEOctober 2019October 2022Allow3610YesNo
16500608SYRINGE TYPE EJECTION DEVICEOctober 2019January 2023Allow3920NoNo
16586275SURFACE MODIFICATION METHOD AND GASKET FOR SYRINGESeptember 2019January 2024Abandon5121NoNo
16566880ADAPTER FOR SINGLE-HANDED OPERATION OF SYRINGE DURING ASPIRATION OPERATIONSeptember 2019October 2022Allow3720YesNo
16564736Plunger for Syringes and SyringesSeptember 2019November 2024Allow6030YesNo
16489243MIDLINE CATHETER PLACEMENT DEVICEAugust 2019November 2021Allow2710NoNo
16545953INTEGRATED PERIPHERAL INTRA-VENOUS CATHETER WITH IMPROVED EXTENSION TUBE PORT PROBE ACCESSAugust 2019June 2023Allow4620YesNo
16525477ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICEJuly 2019April 2022Allow3310YesNo
16479510AUTO-INJECTOR DEVICEJuly 2019March 2020Allow810YesNo
16473247STEERABLE CATHETER SUITABLE FOR LEFT-HAND OPERATIONJune 2019September 2023Allow5131NoNo
16447684CATHETER SECUREMENT, STABILIZATION, AND ANTI-MICROBIAL DEVICEJune 2019October 2022Allow4040YesNo
16438857SEALING CONTAINERJune 2019October 2022Allow4010NoNo
16466505NEEDLE SHIELD REMOVAL MECHANISM FOR INJECTION DEVICEJune 2019April 2022Allow3430YesNo
16344430MEDICAMENT INJECTION DEVICEApril 2019February 2022Allow3320YesNo
16376821PASSIVE SAFETY INTRAOSSEOUS DEVICEApril 2019June 2022Allow3900NoNo
16358707INTRAOSSEOUS DEVICE HAVING RETRACTABLE MOTOR/STYLET ASSEMBLY AND AUTOMATIC STYLET POINT COVER UPON RETRACTION OPERATIONMarch 2019March 2022Allow3610NoNo
16358714COMBINATION INTRAOSSEOUS DRILL AND FLASHLIGHTMarch 2019July 2022Abandon4001NoNo
16359093INTRAOSSEOUS DRILLING DEVICE WITH BARREL HAVING INTERNAL STYLET/MOTOR HOUSING WITH BARREL OPENING EXTENDERMarch 2019December 2022Abandon4510NoNo
16359314DISPOSABLE SINGLE-USE INTRAOSSEOUS DEVICE WITH BATTERY REMOVAL DOORS HAVING LIVING HINGE ON HANDLEMarch 2019July 2022Abandon4010NoNo
16359062FULLY DISPOSABLE SINGLE-USE PASSIVE SAFETY INTRAOSSEOUS DEVICEMarch 2019July 2022Abandon4010NoNo
16359080FOLDABLE, STOWABLE INTRAOSSEOUS DEVICE WITH AUTOMATIC POWER GENERATION WHEN OPENEDMarch 2019September 2022Abandon4201NoNo
16359854INTRAOSSEOUS DEVICE HAVING INTEGRATED MOTOR AND STYLETMarch 2019October 2022Abandon4310NoNo
16359372CANNULA WITH RECESSED HUB STRUCTUREMarch 2019July 2022Abandon4010NoNo
16359868FOLDABLE, STOWABLE INTRAOSSEOUS DEVICE THAT STANDS ALONE ON FLAT SURFACE WHEN UNFOLDEDMarch 2019March 2023Abandon4810NoNo
16326756LIQUID MEDICINE INJECTION DEVICEFebruary 2019September 2019Allow700YesNo
16192331SUTURING NEEDLE FOR INJECTING GOLD THREAD FOR USE OF HAIR LOSS TREATMENTNovember 2018December 2019Allow1320YesNo
16125767PASSIVE SAFETY INTRAOSSEOUS DEVICESeptember 2018May 2022Abandon4401NoNo
16075376TRANSDERMAL PERMEANT APPLICATION DEVICEAugust 2018May 2022Allow4511YesNo
16038967INTRAVENOUS CATHETER WITH PRESSURE ACTIVATED VALVEJuly 2018May 2022Allow4630NoNo
15777490IONTOPHORESIS DEVICE FOR DRUG DELIVERY AND METHOD FOR MANUFACTURING THE SAMEMay 2018October 2022Allow5320NoNo
15947626PERI-VASCULAR TISSUE ABLATION CATHETERSApril 2018May 2020Allow2510NoNo
15945981SURGICAL APPARATUS AND SMOKE DISCHARGING SYSTEMApril 2018January 2022Abandon4620YesNo
15766123SYRINGES WITH PLUNGER ROD DOSE CONTROL MECHANISMApril 2018January 2022Abandon4601NoNo
15766231A POSITION DETERMINATION DEVICE FOR DETERMINING AND REGISTERING AN INJECTION LOCATIONApril 2018September 2022Abandon5320NoNo
15911478Drug Storage and Dispensing System for Pre-Filled ContainersMarch 2018September 2023Allow6050NoNo
15909548HOLLOW NEEDLE FOR ACCESS IN NON-LINEAR PATHMarch 2018May 2022Allow5030YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner IGEL JR, MARK ALAN.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.1%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
7
Allowed After Appeal Filing
4
(57.1%)
Not Allowed After Appeal Filing
3
(42.9%)
Filing Benefit Percentile
86.8%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 57.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner IGEL JR, MARK ALAN - Prosecution Strategy Guide

Executive Summary

Examiner IGEL JR, MARK ALAN works in Art Unit 3783 and has examined 179 patent applications in our dataset. With an allowance rate of 68.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner IGEL JR, MARK ALAN's allowance rate of 68.2% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by IGEL JR, MARK ALAN receive 1.83 office actions before reaching final disposition. This places the examiner in the 56% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by IGEL JR, MARK ALAN is 37 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +34.8% benefit to allowance rate for applications examined by IGEL JR, MARK ALAN. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 32.1% of applications are subsequently allowed. This success rate is in the 59% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 39.1% of cases where such amendments are filed. This entry rate is in the 52% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 85.7% of appeals filed. This is in the 77% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 60.0% are granted (fully or in part). This grant rate is in the 77% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.